PRE Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 -7.63%, SMA50 0.58%, SMA200 45.06%). The stock’s 14-day RSI is 47.45 (neutral), while the ATR of 1.75 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -22.09% below its high and over 475.49% above its low. Average 10-day trading volume of 150.17 thousand shares is below the 3-month average of 250.27 thousand, indicating normal recent market interest.

Prenetics Global Limited has 11.45 million shares outstanding. The public float is 9.15 million shares, elevated short interest at 0.39% of float. This equals 41.28 thousand shares. The short ratio is 1.02 days. Institutional investors hold 15.81% of the float. Insiders own 19.88%. Clarke Emmanuel holds 39.40 thousand shares, Desmet Laurie has 38.39 thousand shares and Walker Theodore C has 32.99 thousand shares.

Prenetics Global Limited generated EPS of -$4.11 over the past year. Five-year average earnings growth is 27.19%. The latest quarter delivered EPS of -$0.41. The next quarter is forecast at -$0.61. Next year's EPS is expected at $86.52. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $32.00 to $29.00. The high target offers 75.82% upside. The low target suggests 59.34% downside. The mean target is $30.50. This offers 67.58% upside. Prenetics Global Limited earnings surprise history is a mixed track record. The quarter that ended November 10, 2025, missed forecasts by -25.45%. The prior quarter beat by 15.49%. Over the last six quarters, Apple has recorded several small beats. These include -83.87% in September 27, 2024.

Prenetics Global Limited last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$18.54. This means the shares are trading below this model’s fair value.

Prenetics Global Limited (NASDAQ:PRE) closed at $18.20 USD, gaining $0.37 (2.08%) from the previous close of $17.83. The stock is currently mid-range between its 52-week high and low $4.15 and $23.63. With a market capitalization of about $255.78 million, Prenetics Global Limited is classified as a micro-cap and shows lower-than-market volatility (beta ~0.27). Key stats such as the average daily volume over the past year has been around 246.44 thousand shares, in line with its 52-week average. Headquartered in Quarry Bay, None, Prenetics Global Limited operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Sheng Wu Yeung, the company employs approximately 285 people and listed since July 16, 2021. Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company.

Prenetics Global Limited (NASDAQ:PRE) shares are flat 3.05% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Prenetics Global Limited trading at a premium to the broader market with a P/E of -4.95. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $12.50, suggesting -31.32% downside. Our AI forecast model points to short-term weakness (-9.34% over two weeks), a medium-term rise (140.6% over three months), and a longer-term gain (8.41% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Prenetics Global Limited stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -9.34%, with price expected at $16.50 by May 04, 2026, within a range of $15.32 to $17.69 3-Month Outlook: Projected rise of 140.6%, reaching $43.79 by July 16, 2026, with a range of $43.41 to $44.23. 1-Year Outlook: Projected gain of 8.41%, with price at $19.73 by April 20, 2027, within a range of $18.17 to $21.93.

Prenetics Global Limited trades at a P/E ratio of -4.95, slightly below the S&P 500 average, with a price-to-sales ratio of 2.66 and a price-to-book ratio of 1.65 suggesting the stock is closer to book value. The P/FCF stands at -11.48, also below market averages.